EarningsQ2 2025 Earnings Report

Sarepta Therapeutics (AB3A) Q2 2025 Earnings Report

6 Followers

DE:AB3A Q2 2025 EPS Results

Actual EPS€1.69

Consensus EPS€0.74

Beat/MissBeat by +€0.95

One Year Ago EPS€0.06

Actual Revenue€547.11M

Expected Revenue€475.10M

Beat/MissBeat by +€72.01M

YoY Revenue Growth+68.38%

QuarterQ2 2025

Date08/06/2025

TimeAfter Close

Conference CallWednesday, August 6, 2025

DE:AB3A Upcoming Earnings

Sarepta Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	0.10 / -	-1.612	―
Aug 05, 2026	2026 (Q2)	0.19 / -0.04	1.692	-102.65% (-1.74)
May 06, 2026	2026 (Q1)	0.87 / 2.58	-4.118	162.61% (+6.70)
Feb 25, 2026	2025 (Q4)	-1.07 / -3.52	1.343	-362.00% (-4.86)
Nov 03, 2025	2025 (Q3)	-0.65 / -1.61	0.304	-629.41% (-1.92)
Aug 06, 2025	2025 (Q2)	0.74 / 1.69	0.063	2600.00% (+1.63)
May 06, 2025	2025 (Q1)	-2.87 / -4.12	0.331	-1343.24% (-4.45)
Feb 26, 2025	2024 (Q4)	1.69 / 1.34	0.421	219.15% (+0.92)
Nov 06, 2024	2024 (Q3)	-0.07 / 0.30	-0.412	173.91% (+0.72)
Aug 07, 2024	2024 (Q2)	-0.12 / 0.06	-0.242	125.93% (+0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed